Леналидомид Гриндекс

Леналидомид Гриндекс is an oral immunomodulatory agent used in certain blood disorders. This EU-manufactured lenalidomide supports immune system regulation. Consult healthcare provider for suitability. Short-term storage guidance may apply.

Lenalidomide is primarily used to treat myelodysplastic syndromes and multiple myeloma. It modulates the immune system to help control abnormal blood cell production. Patients often ask what lenalidomide is used for in these conditions. It may also be prescribed for other immune-related blood disorders as determined by a physician.

Common effects include changes in blood cell counts and immune response. Some users report fatigue or gastrointestinal discomfort. These effects vary and are not experienced by everyone. Regular monitoring helps manage any changes during treatment.

Store lenalidomide in a secure, dry place away from moisture and direct light. Keep out of reach of children and pets. Follow local disposal guidelines for unused medication. Consult a healthcare provider before starting or stopping this medication.

Lenalidomide may interact with other medications affecting the immune system or blood cell production. Alcohol and certain supplements could influence effects. Always inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.